| Gabriel Carlos Monthan, MD | |
|
241 Laguayra Dr Ne, Albuquerque, NM 87108-1723 | |
| (505) 573-7770 | |
| Not Available |
| Full Name | Gabriel Carlos Monthan |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 241 Laguayra Dr Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033401831 | NPI | - | NPPES |
| Entity Name | County Of Butte |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578623583 PECOS PAC ID: 3779489356 Enrollment ID: O20031212000445 |
News Archive
XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of unmet clinical needs with a focus on treatments for autoimmune diseases, today announced that it has reached agreement with Yeda Research and Development Company Ltd. to amend the development milestones in the License Agreement signed between the parties in January 2014 for the development of hCDR1 for the treatment of systemic lupus erythematosus (SLE).
The American Gastroenterological Association (AGA), the leading association representing clinicians and researchers who specialize in the digestive tract, and MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today the collaborative initiative to develop a set of registries to assist physicians, payors, policy makers, and other healthcare stakeholders in the study and improvement of clinical and quality outcomes, care management, and cost effectiveness of care delivered to Americans with gastrointestinal disease.
MO BIO Laboratories, Inc., the leader in microbial, stool, plant, and soil nucleic acid purification, announces the launch of the PowerClean Pro DNA and RNA Clean-Up Kits, featuring a fast, 7 minute protocol for removal of amplification inhibitors including humic substances, polysaccharides, polyphenolics, heme, and lipids from purified DNA or RNA.
2 to 3 % of the children are born with an intellectual disability. Possibly by a genetic defect, but in 80% of these cases, we do not know - yet - which genes are responsible. VIB researchers at KU Leuven show that increased production of the HUWE1 protein is the cause in some patients.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gabriel Carlos Monthan, MD 241 Laguayra Dr Ne, Albuquerque, NM 87108-1723 Ph: (505) 573-7770 | Gabriel Carlos Monthan, MD 241 Laguayra Dr Ne, Albuquerque, NM 87108-1723 Ph: (505) 573-7770 |
News Archive
XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of unmet clinical needs with a focus on treatments for autoimmune diseases, today announced that it has reached agreement with Yeda Research and Development Company Ltd. to amend the development milestones in the License Agreement signed between the parties in January 2014 for the development of hCDR1 for the treatment of systemic lupus erythematosus (SLE).
The American Gastroenterological Association (AGA), the leading association representing clinicians and researchers who specialize in the digestive tract, and MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today the collaborative initiative to develop a set of registries to assist physicians, payors, policy makers, and other healthcare stakeholders in the study and improvement of clinical and quality outcomes, care management, and cost effectiveness of care delivered to Americans with gastrointestinal disease.
MO BIO Laboratories, Inc., the leader in microbial, stool, plant, and soil nucleic acid purification, announces the launch of the PowerClean Pro DNA and RNA Clean-Up Kits, featuring a fast, 7 minute protocol for removal of amplification inhibitors including humic substances, polysaccharides, polyphenolics, heme, and lipids from purified DNA or RNA.
2 to 3 % of the children are born with an intellectual disability. Possibly by a genetic defect, but in 80% of these cases, we do not know - yet - which genes are responsible. VIB researchers at KU Leuven show that increased production of the HUWE1 protein is the cause in some patients.
› Verified 6 days ago
Melissa A Merhege, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 500 Walter St Ne Ste 213, Albuquerque, NM 87102 Phone: 505-727-7177 Fax: 505-727-3778 | |
Dr. Anju C Jaiswal, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Children Psychiatric Hospital, 1001 Yale Blvd., Albuquerque, NM 87131 Phone: 505-272-2890 | |
George Edwin Davis, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1002 Idlewilde Ln Se, Albuquerque, NM 87108 Phone: 505-270-7479 | |
Shannon Stromberg, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Unm Psychiatric Ctr, 2600 Marble Ne, Albuquerque, NM 87131 Phone: 505-272-2800 Fax: 505-272-8692 | |
Liz-beth Porter, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Unm Hospital Psychiatry, 2211 Lomas Blvd Ne, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Mr. Ronald Lee Romanik, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7520 Montgomery Blvd Ne, Suite D12, Albuquerque, NM 87109 Phone: 505-323-6969 Fax: 505-323-9696 | |
Dr. Justin F Beatty, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Msc 09 5030 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-2223 |